ValuEngine upgraded shares of iRadimed Corporation (NASDAQ:IRMD) from a sell rating to a hold rating in a report released on Friday, October 6th.
IRMD has been the topic of a number of other research reports. Roth Capital raised shares of iRadimed Corporation from a neutral rating to a buy rating and upped their target price for the company from $9.00 to $12.00 in a research report on Monday, July 31st. TheStreet upgraded shares of iRadimed Corporation from a d rating to a c- rating in a research note on Friday, June 23rd. Finally, Zacks Investment Research upgraded shares of iRadimed Corporation from a hold rating to a buy rating and set a $11.00 price target on the stock in a research note on Friday, August 4th.
iRadimed Corporation (NASDAQ:IRMD) opened at 10.05 on Friday. The stock has a market cap of $106.35 million, a PE ratio of 42.05 and a beta of 1.47. iRadimed Corporation has a 12 month low of $7.85 and a 12 month high of $14.24. The company has a 50-day moving average of $9.99 and a 200-day moving average of $9.10.
iRadimed Corporation (NASDAQ:IRMD) last announced its quarterly earnings results on Friday, July 28th. The medical equipment provider reported $0.06 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.07. The firm had revenue of $5.50 million for the quarter, compared to analysts’ expectations of $5.41 million. iRadimed Corporation had a net margin of 11.61% and a return on equity of 8.98%. The company’s revenue was down 44.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.24 EPS. On average, equities analysts forecast that iRadimed Corporation will post $0.13 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “iRadimed Corporation (IRMD) Upgraded at ValuEngine” was first posted by BBNS and is the property of of BBNS. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://baseballnewssource.com/markets/iradimed-corporation-irmd-lifted-to-hold-at-valuengine/1700738.html.
Several hedge funds have recently added to or reduced their stakes in the stock. Ameriprise Financial Inc. purchased a new stake in shares of iRadimed Corporation during the second quarter worth approximately $2,954,000. AQR Capital Management LLC increased its stake in shares of iRadimed Corporation by 25.9% during the first quarter. AQR Capital Management LLC now owns 137,663 shares of the medical equipment provider’s stock worth $1,225,000 after buying an additional 28,345 shares during the period. Globeflex Capital L P increased its stake in shares of iRadimed Corporation by 92.0% during the first quarter. Globeflex Capital L P now owns 85,151 shares of the medical equipment provider’s stock worth $758,000 after buying an additional 40,800 shares during the period. Menta Capital LLC increased its stake in shares of iRadimed Corporation by 5.7% during the second quarter. Menta Capital LLC now owns 70,476 shares of the medical equipment provider’s stock worth $606,000 after buying an additional 3,823 shares during the period. Finally, Oxford Asset Management increased its stake in shares of iRadimed Corporation by 85.4% during the first quarter. Oxford Asset Management now owns 65,663 shares of the medical equipment provider’s stock worth $584,000 after buying an additional 30,238 shares during the period. Hedge funds and other institutional investors own 14.19% of the company’s stock.
iRadimed Corporation Company Profile
IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for iRadimed Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRadimed Corporation and related companies with our FREE daily email newsletter.